Team Finland Health Visit to New York and Boston

This visit will provide unique access to research institutions, hospitals, innovation ecosystems, and investors, enabling Finnish companies to build high-level connections, explore collaboration opportunities, and strengthen Finland’s visibility as a world-class health innovation partner. 

Why the U.S. East Coast?

The U.S. East Coast is home to the world’s most concentrated and influential health innovation ecosystems, combining world-class academic research, top-tier hospitals, global pharma and biotech companies, and a powerful investor network. 

READ MORE

Preliminary program highlights

The final itinerary is subject to change based on company participation and the availability of meeting hosts.

New York, March 23

• Deerfield Management – a leading healthcare investment firm and translational research partner.
• Cure Innovation Hub – an ecosystem connecting innovators from concept to commercialization.
• Pfizer visit
• Orion visit
• Memorial Sloan Kettering – a global leader in cancer research and treatment.
• NYC EDC

Boston, March 24-25 (possibility to attend the conference on the 26th)

• Broad Institute – world-leading research in genomics and disease biology.
• MIT Industrial Liaison Program – connecting industry with cutting-edge MIT research and innovation.
• LabCentral – a premier incubator supporting early-stage biotech startups.
• MassBIO & MassMEDIC – industry organizations driving growth across the life science and medtech sectors.
• Cambridge Innovation Center (CIC) – a hub for global collaboration and startup activity in Kendall Square.
• Brigham and Women’s Hospital and Boston Children’s Hospital – leading academic medical centers and teaching hospitals of Harvard Medical School, located in the
• Longwood Medical Area, which hosts numerous world-leading hospitals, health schools, and research institutes. There is a possibility to meet with innovation and research teams fostering startup and innovation programs across the hospital system.
• MassBio’s 2026 State of Possible Conference, March 26

Who Should attend? 

This delegation is open to Finnish companies and organizations in the health and life sciences sectors that are already active in the U.S. market and seeking growth, partnerships, and visibility, including: 

• Oncology and immunology
• Imaging
• Health data and AI
• Pharma

Participants will gain

• First-hand insights into U.S. hospital innovation and investment models
• Access to decision-makers at leading U.S. hospitals, research institutions, and venture funds
• Networking opportunities with East Coast healthcare leaders
• Access, visibility, and credibility through the Team Finland delegation

Participation fee

To cover the expenses related to arranging the visit in New York and Boston on March 23-26, 2026, a maximum participation fee will be invoiced as follows:

• Micro businesses and SMEs: EUR 1190 + 25,5% VAT per person
• Major companies: EUR 1400 + 25,5% VAT per person

A 25% discount on the participation fee will be granted for each additional representative from the participating company. The participation fee will be invoiced after the visit, based on the actual costs. The invoiced fee will not exceed the amounts mentioned above. The participation fee does not include flights or accommodation of the delegate nor meals outside the visit program

READ MORE